Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis

被引:20
作者
Fukuta, D
Miyagawa, S
Yamada, M
Matsunami, K
Kurihara, T
Shirasu, A
Hattori, H
Shirakura, R
机构
[1] Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Regenerat Med, Suita, Osaka 5650871, Japan
[2] Anim Engn Res Inst, Ibaraki, Japan
[3] Nipro Corp, Res & Dev Lab, Osaka, Japan
关键词
C1-INH; complement; xenograft;
D O I
10.1034/j.1399-3089.2003.01120.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of the present study was to assess the effect of various forms of the surface-bound form of the C1 esterase inhibitor (C1-INH-PI) and decay accelerating factor (DAF) on xenogenic cells. cDNAs of various deletion mutants of the C1-INH-PI, such as delta-1-99 amino acid (AA), delta-108-183AA loop, delta-whole loop, delta-exon5, delta-exon6 + 7, and delta-exon5 + 6 + 7, and that of DAF, the delta-short consensus repeat (SCR) 1-DAF were established. While all deletion mutants of C1-INH-PI except the delta-1-99AA were expressed in the cytoplasm but not on the cell surface, the delta-1-99AA was clearly expressed on the xenogeneic cell surface. Amelioration of complement-mediated xenogeneic cell lysis by delta-1-99AA was next tested, and compared with delta-SCR1 DAF. Both molecules blocked human complement-mediated cell lysis by approximately 57 to 90 and 93 to 98%, respectively, in Chinese hamster ovarian tumor (CHO) cells and pig endothelial cells (PECs). The CHO cell transfectants were incubated with 20% normal human serum, and the amounts of C4 and C3 deposition on the cell surface were analysed by flow cytometry. The DAF transfectant showed a large amount of C4-deposition and much less C3-deposition than the controls (approximately 85% suppression), whereas the delta-1-99AA showed approximately a 40% suppression in both C4- and C3-deposition. Consequently, both the delta-1-99AA C1-INH-PI and delta-SCR1 DAF molecules are quite effective in down-regulating the xenogeneic cell lysis, but accomplished this in different manners.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 50 条
  • [1] The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1)
    Windfuhr, JP
    Alsenz, J
    Loos, M
    MOLECULAR IMMUNOLOGY, 2005, 42 (06) : 657 - 663
  • [2] Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis
    Miyagawa, Shuji
    Fukuta, Daisuke
    Kitano, Etsuko
    Kobayashi, Chizuko
    Fumimoto, Yuichi
    Shirasu, Akio
    Hattori, Hiroyuki
    Shirakura, Ryota
    Fukuzawa, Masahiro
    XENOTRANSPLANTATION, 2006, 13 (05) : 433 - 439
  • [3] Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
    Fragnan, N. T. M. L.
    Tolentino, A. L. N.
    Borba, G. B.
    Oliveira, A. C.
    Simoes, J. A.
    Palma, S. M. U.
    Constantino-Silva, R. N.
    Grumach, A. S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2018, 51 (12)
  • [4] C1-inhibitor (C1-INH) autoantibodies in hereditary angioederna Strong correlation with the severity of disease in C1-INH concentrate nalve patients
    Varga, Lilian
    Szeplaki, Gabor
    Visy, Beata
    Fust, George
    Harmat, George
    Miklos, Katalin
    Nemeth, Julianna
    Cervenak, Laszlo
    Karadi, Istvan
    Farkas, Henriette
    MOLECULAR IMMUNOLOGY, 2007, 44 (06) : 1454 - 1460
  • [5] Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia
    Roesch, Erin
    Broome, Catherine
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (06) : 20 - 25
  • [6] Features of a newly cloned pig C1 esterase inhibitor
    Kobayashi, Chizuko
    Matsunami, Katsuyoshi
    Omori, Takeshi
    Nakatsu, Shino
    Nakahata, Kengo
    Xu, Hengjie
    Shirakura, Ryota
    Fukuzawa, Masahiro
    Miyagawa, Shuji
    JOURNAL OF BIOCHEMISTRY, 2006, 140 (03) : 421 - 427
  • [7] Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis
    Radanova, Maria
    Vasilev, Vasil
    Mihaylova, Galya
    Kosturkova, Mariya
    Kishore, Uday
    Roumenina, Lubka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [8] C1 esterase inhibitor and the contact system in COVID-19
    Thomson, Timothy M.
    Toscano-Guerra, Emily
    Casis, Ernesto
    Paciucci, Rosanna
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (04) : 520 - 524
  • [9] TERMINAL COMPLEMENT COMPLEXES AND C1/C1 INHIBITOR COMPLEXES IN RHEUMATOID-ARTHRITIS AND OTHER ARTHRITIC CONDITIONS
    OLEESKY, DA
    DANIELS, RH
    WILLIAMS, BD
    AMOS, N
    MORGAN, BP
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 84 (02) : 250 - 255
  • [10] Protective effect of C1 esterase inhibitor on acute traumatic spinal cord injury in the rat
    Tei, Rinsei
    Kaido, Takanobu
    Nakase, Hiroyuki
    Sakaki, Toshisuke
    NEUROLOGICAL RESEARCH, 2008, 30 (07) : 761 - 767